Fabian Fischer

Publication Activity (10 Years)

Years Active: 2021-2022
Publications (10 Years): 4

Top Topics

Drosophila Melanogaster

Drug Administration

Top Venues

Future medicinal chemistry

Molecular cancer therapeutics

Molecules (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Aaron Burmeister, Alexa Stephan, Leandro A Alves Avelar, Melanie R Müller, Andrea Seiwert, Stefan Höfmann, Fabian Fischer, Hector Torres-Gomez, Michèle Janine Hoffmann, Guenter Niegisch, Felix Bremmer, Patrick Petzsch, Karl Köhrer, Peter Albers, Thomas Kurz, Margaretha A Skowron, Daniel Nettersheim
Establishment and Evaluation of Dual HDAC/BET Inhibitors as Therapeutic Options for Germ Cell Tumors and Other Urological Malignancies. Molecular cancer therapeutics 21 (11) (2022)
Fabian Fischer, Leandro A Alves Avelar, Laoise Murray, Thomas Kurz
Designing HDAC-PROTACs: lessons learned so far. Future medicinal chemistry 14 (3) (2021)
Fabian Fischer, Leandro A Alves Avelar
A short overview of resistance to approved histone deacetylase inhibitors. Future medicinal chemistry 13 (14) (2021)
Aya C Taki, Abdul Jabbar, Thomas Kurz, Beate Lungerich, Guangxu Ma, Joseph J Byrne, Marc Pflieger, Yodita Asfaha, Fabian Fischer, Bill C H Chang, Robin B Gasser, Robin B Gasser
Three Small Molecule Entities (MPK18, MPK334 and YAK308) with Activity against Haemonchus contortus In Vitro. Molecules (Basel, Switzerland) 26 (9) (2021)